M. Bastos Oreiro

SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment

L. Bento, Antonia Rodríguez, A. Sureda, 2021, Cancers.

EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

I. Buño, J. Menárguez, C. Martínez-Laperche, 2022, BMC Cancer.

Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing

I. Buño, J. Díez-Martín, C. Martínez-Laperche, 2023, Cancers.

[Lymphoproliferative disorders in an inflammatory bowel disease unit].

M. van Domselaar, A. López San Román, M. Bastos Oreiro, 2010, Gastroenterologia y hepatologia.